Publications by authors named "Daniel Fresan"

Claim this Profile
O
Optimizing linezolid dosing for nosocomial urinary tract infections in critically ill patients with renal impairment.
Adela Benítez-Cano, Xin Liu, Haiping Xu, Xinyi Tang, Luigi Zattera, Daniel Fresan

Int J Antimicrob Agents· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of aztreonam/avibactam in a critically ill patient with a class B metallo-β-lactamase producing Enterobacteriaceae and receiving continuous renal replacement therapy.
Daniel Fresán, Maria Pilar Gracia-Arnillas, Aitor Iriarte Zugasti, Cristina Raich Gual, Carla Comajuán Mendoza

J Antimicrob Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An easy-to-use predictive score for identifying patients at risk of suboptimal linezolid exposure and candidates for therapeutic drug monitoring.
Daniel Fresán, Luisa Sorlí, Jaume Barceló-Vidal, Ana Rodrigo-Moreno, Rosana Muñoz

Int J Antimicrob Agents· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world experience of therapeutic drug monitoring and PK/PD achievement of ceftaroline administered by different infusion regimens in patients with confirmed infections caused by Gram-positive bacteria.
Daniel Fresán, Sonia Luque, Adela Benítez-Cano, Luisa Sorlí, María Milagro Montero

J Antimicrob Chemother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics/pharmacodynamics and therapeutic drug monitoring of ceftazidime/avibactam administered by continuous infusion in patients with MDR Gram-negative bacterial infections-authors' response.
Daniel Fresán, Sonia Luque, Luisa Sorlí, Santiago Grau

J Antimicrob Chemother· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis